GlassScriptPhysician profile
Audra Cole
NPI 1104210830
$3,260.35
in general payments reported to CMS, 2019-2025
29 companies · $712 in 2025
The $712 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $26.03 · 2021: $817 · 2022: $516 · 2023: $601 · 2024: $335 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $833.80 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $370.54 | 2023-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $313.21 | 2022-2025 | Preveleak, Coseal, Perclot |
| Mayne Pharma Commercial LLC | $214.76 | 2022-2025 | |
| Exeltis, USA INC. | $206.80 | 2021-2024 | Slynd |
| Pfizer INC. | $145.76 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.08 | 2021-2025 | |
| Organon LLC | $109.37 | 2021-2025 | Nexplanon, Jada System |
| Amag Pharmaceuticals, INC. | $102.45 | 2019 | |
| Biogen, INC. | $98.27 | 2025 | Zurzuvae |
| Gynesonics, INC. | $93.89 | 2021 | |
| Millicent US INC | $93.85 | 2025 | Femlyv, Intrarosa |
| Hologic Sales and Service, LLC | $68.09 | 2021-2023 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Medtronic, INC. | $64.24 | 2021-2023 | Ligasure, V-Loc 180 |
| Myovant Sciences INC. | $48.30 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $38.33 | 2022 | |
| Exact Sciences Corporation | $37.41 | 2023-2024 | Cologuard Collection Kit |
| Intuitive Surgical, INC. | $35.45 | 2024 | |
| Minerva Surgical, INC | $35.37 | 2023 | |
| Lilly USA, LLC | $34.32 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $29.46 | 2021-2022 | |
| Boston Scientific Corporation | $26.35 | 2024 | Advantage System |
| Medtronic USA, INC. | $26.03 | 2020 | |
| Mylan Pharmaceuticals INC. | $22.93 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.50 | 2022 | |
| Evofem Biosciences, INC. | $18.25 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.17 | 2021 | |
| Currax Pharmaceuticals LLC | $13.85 | 2021 | |
| Channel Medsystems, INC. | $11.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.